IE 11 is not supported. For an optimal experience visit our site on another browser.

MusclePharm Invited to Present at HIV DART(TM) 2010 Medical Conference

DENVER, Nov. 15, 2010 (GLOBE NEWSWIRE) -- MusclePharm® Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States, has been invited to present at the upcoming HIV DART™ 2010: Frontiers in Drug development for Antiretroviral Therapies Conference being held from December 7-10, 2010 in Los Cabos, Mexico.
/ Source: GlobeNewswire

DENVER, Nov. 15, 2010 (GLOBE NEWSWIRE) -- MusclePharm® Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States, has been invited to present at the upcoming HIV DART™ 2010: Frontiers in Drug development for Antiretroviral Therapies Conference being held from December 7-10, 2010 in Los Cabos, Mexico.

This innovative conference, HIV DART 2010, will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community an increased understanding of the current and future challenges in therapeutics for HIV infection. This brings leaders in the research community together to advance the medical communities knowledge of the ongoing drug development processes in antiretroviral research.

At this year's HIV DART 2010 Conference, MusclePharm will present its results on the use of its product, Recon, in HIV patients. Early results show that Recon may help prevent the onset of wasting syndrome by facilitating the growth and maintenance of muscle mass in people living with HIV, which has been associated with antiretroviral drug resistance.

MusclePharm's President, Cory Gregory stated, "We started MusclePharm to enable people of all fitness levels to maintain and improve their general fitness through a daily nutritional supplement regimen.   We are very pleased to have our work accepted by such a prestigious group of physicians and researchers focused on improving the lives of people with the HIV virus."

Mr. Gregory continued, "This conference is well known for its prominent list of attendees, which includes the greatest minds HIV research has to offer. The fact that the scientific committee at HIV DART 2010 viewed our work as significant and ground breaking shows the scientific strength of our products and great promise for the future use of therapeutic nutritional supplements for the treatment of HIV disease."  

Recon contains important amino acids, assisting in reaching the higher levels of nutrition required for people living with HIV. MusclePharm's Recon Nutritional Supplement is easily digestible, helps the absorption of amino acids and proteins. It contains essential minerals, digestive enzymes, Glutamine and other metabolic agents that maximize recovery, protein synthesis and endurance.

MusclePharm recently presented its findings on the use of Recon to prevent and treat wasting syndrome in HIV patients at XVIII International AIDS Conference this past July in Vienna, Austria at the Research Advances satellite symposium sponsored by the National Association of People with AIDS and The AIDS Institute. The Company also presented this past week at the 138th Annual Meeting of the American Public Health Association in Denver, CO.

MusclePharm is currently striving to obtain Medicaid approval for the product in states with designated Eligible Metropolitan Areas under the Ryan White HIV/AIDS Treatment Modernization Act.  

MusclePharm has recently expanded their market to include therapeutic medical modalities beginning with the utilization of Recon, a multi-component therapeutic nutritional supplement in the treatment of people living with HIV and AIDS.

About MusclePharm

Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that develops and manufacturers a full line of NSF and scientifically approved nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. The Company's propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 US retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com. For more information, please visit .

Forward-looking Statements

MusclePharm Corporation believes the information set forth in this Press Release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Certain factors that could cause results to differ materially from those projected in the forward-looking statements are set forth in "Risk Factors" in Item 2.02 of the Company's Form 8-K dated February 18, 2010, which has been filed with the Securities and Exchange Commission.

CONTACT: ICR Investor Contact: John Mills, Senior Managing Director 310.954.1105